Search research articles
Contact Us
Filters
Showing results (31-40 of 459) with videos related to
Page
of 46
Sort By:
American Journal of Clinical Oncology
|
December 2, 2014
High-risk Prostate Cancer Treated With Dose-escalated RT: An Analysis of Hormonal Therapy Use and Duration, and Prognostic Implications of PSA Nadir ≤0.2 to Select Men for Short-term Hormonal Therapy
Christina H Son, Daniel A Hamstra, Felix Y Feng, et al.
Nature Reviews. Clinical Oncology
|
June 2, 2016
Translational and clinical implications of the genetic landscape of prostate cancer
Daniel E Spratt, Zachary S Zumsteg, Felix Y Feng, et al.
EJNMMI Physics
|
September 30, 2022
Impact of radiopharmaceutical therapy (<sup>177</sup>Lu, <sup>225</sup>Ac) microdistribution in a cancer-associated fibroblasts model
Jonathan Tranel, Stig Palm, Stephen A Graves, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 2, 2019
Reply to J.B. Aragon-Ching
Seth A Rosenthal, Chen Hu, Oliver Sartor, et al.
Molecular Cell
|
June 20, 2015
Chromatin to Clinic: The Molecular Rationale for PARP1 Inhibitor Function
Felix Y Feng, Johann S de Bono, Mark A Rubin, et al.
Cancer Discovery
|
February 20, 2020
Transcription-Associated Cyclin-Dependent Kinases as Targets and Biomarkers for Cancer Therapy
Jonathan Chou, David A Quigley, Troy M Robinson, et al.
Medical Physics
|
February 5, 2024
Technical note: Errors introduced when using Dose Voxel Kernels for estimating absorbed dose from radiopharmaceutical therapies involving alpha emitters
Jonathan Tranel, Stig Palm, Felix Y Feng, et al.
Cancer
|
October 20, 2011
Interval to biochemical failure as a biomarker for cause-specific and overall survival after dose-escalated external beam radiation therapy for prostate cancer
Nirav S Kapadia, Karin Olson, Howard M Sandler, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 7, 2013
Retrospective evaluation reveals that long-term androgen deprivation therapy improves cause-specific and overall survival in the setting of dose-escalated radiation for high-risk prostate cancer
Felix Y Feng, Kevin Blas, Karin Olson, et al.
American Journal of Clinical Oncology
|
September 26, 2013
Time to Nadir PSA: Of Popes and PSA--The Immortality Bias
Skyler B Johnson, William C Jackson, Jure Murgic, et al.
Page
of 46
Search research articles
Search
Showing results (31-40 of 459) with videos related to
Sort By:
Page
of 46
American Journal of Clinical Oncology
|
December 2, 2014
High-risk Prostate Cancer Treated With Dose-escalated RT: An Analysis of Hormonal Therapy Use and Duration, and Prognostic Implications of PSA Nadir ≤0.2 to Select Men for Short-term Hormonal Therapy
Christina H Son, Daniel A Hamstra, Felix Y Feng, et al.
Nature Reviews. Clinical Oncology
|
June 2, 2016
Translational and clinical implications of the genetic landscape of prostate cancer
Daniel E Spratt, Zachary S Zumsteg, Felix Y Feng, et al.
EJNMMI Physics
|
September 30, 2022
Impact of radiopharmaceutical therapy (<sup>177</sup>Lu, <sup>225</sup>Ac) microdistribution in a cancer-associated fibroblasts model
Jonathan Tranel, Stig Palm, Stephen A Graves, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 2, 2019
Reply to J.B. Aragon-Ching
Seth A Rosenthal, Chen Hu, Oliver Sartor, et al.
Molecular Cell
|
June 20, 2015
Chromatin to Clinic: The Molecular Rationale for PARP1 Inhibitor Function
Felix Y Feng, Johann S de Bono, Mark A Rubin, et al.
Cancer Discovery
|
February 20, 2020
Transcription-Associated Cyclin-Dependent Kinases as Targets and Biomarkers for Cancer Therapy
Jonathan Chou, David A Quigley, Troy M Robinson, et al.
Medical Physics
|
February 5, 2024
Technical note: Errors introduced when using Dose Voxel Kernels for estimating absorbed dose from radiopharmaceutical therapies involving alpha emitters
Jonathan Tranel, Stig Palm, Felix Y Feng, et al.
Cancer
|
October 20, 2011
Interval to biochemical failure as a biomarker for cause-specific and overall survival after dose-escalated external beam radiation therapy for prostate cancer
Nirav S Kapadia, Karin Olson, Howard M Sandler, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 7, 2013
Retrospective evaluation reveals that long-term androgen deprivation therapy improves cause-specific and overall survival in the setting of dose-escalated radiation for high-risk prostate cancer
Felix Y Feng, Kevin Blas, Karin Olson, et al.
American Journal of Clinical Oncology
|
September 26, 2013
Time to Nadir PSA: Of Popes and PSA--The Immortality Bias
Skyler B Johnson, William C Jackson, Jure Murgic, et al.
Page
of 46